Intervention

Lenvatinib Pill

ClinicalTrials.gov intervention label

Clinical trials1
Recruiting0
Common conditions22
Lead sponsors shown1

Common conditions

Advanced Solid Tumor1Cancer1Clear Cell Renal Cell Carcinoma1Colorectal Adenocarcinoma1Colorectal Cancer1Epithelial Ovarian Cancer1Gastric Adenocarcinoma1GastroEsophageal Cancer1Hepatocellular Carcinoma1Luminal Breast Cancer1Melanoma1Metastatic Cancer1Non-small Cell Lung Cancer1Pancreatic Adenocarcinoma1Papillary Renal Cell Carcinoma1Small-cell Lung Cancer1Squamous Cell Carcinoma of Head and Neck1Squamous Cell Carcinoma Skin1Thyroid Cancer1Triple Negative Breast Cancer1Tumor, Solid1Urothelial Carcinoma1

Trial status mix

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE11
PHASE21

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.